The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
Heavy rainfall and flooding caused overall vehicle sales in the Philippines to fall 18 percent year-on-year
The Philippines reclaimed its position as the world’s second-largest banana exporter in 2025, according to the
DHL Express will raise its average shipping rates in the Philippines by 5.9 percent starting Jan.
The National Food Authority (NFA) expects to miss its 790,000-metric-ton palay procurement target this year due
The Philippines has received an additional 9,151 metric tons raw value (MTRV) quota to export raw